RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
Rafael Holdings, Inc.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 11, 2026
$1.29−0.10 (-7.19%)
Close on Oct 19, 2026
- Market cap
- $66.09M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.03 (−2.27%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Rafael Holdings, Inc. grew revenue 33.9% to $980.00K over the twelve months to Apr 30, 2026. Free cash flow was -$18.93M.
Revenue
$980.00K
+33.9% vs. a year earlier
Operating income
-$36.43M
TTM Q3 2026
Free cash flow
-$18.93M
FY2025
EPS, diluted
-$1.04
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Apr 30, 2026
Valuation
- Market cap
- $66.09M
- P/E ratio
- –
- Price to sales
- 67.43
- Price to book
- 0.88
- Dividend yield
- –
- Free cash flow yield
- -28.64%
Fundamentals
- Revenue
- $980.00K
- Net income
- -$20.75M
- EPS, diluted
- -$1.04
- Free cash flow
- -$18.93M
- Book value per share
- $1.47
- Diluted shares
- 51M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
$980.00K+33.9% YoY
Gross profit
–
Operating income
-$36.43M
Net income
-$20.75M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months